Roy Vagelos
$1.08B
as of 10/04/24
About Roy Vagelos
Roy Vagelos served as the chairman and chief executive officer of Merck & Co. from 1984 to 1994.
Vagelos graduated from the University of Pennsylvania in 1950 and earned an M.D. at Columbia University in 1954.
He joined Regeneron Pharmaceuticals as chairman in 1995 and led the company for nearly 29 years.
He also served as chairman of Theravance, a pharmaceutical company he cofounded in 1996.
Vagelos has authored over 100 scientific papers and is an elected member of the National Academy of Sciences.
Personal stats
Citizenship
United States of AmericaSource of wealth
pharmacueticalsResidence
Gladstone, New JerseySelf-made
self-madeRoy Vagelos’s fortune is worth
18K
troy ounces of gold
17K
median U.S. household
11K
median U.S. income
0.022%
U.S. credit card volume
0.004%
GDP of the United States
0.003%
United States debt
Net worth history
Annual ranking
Related people
Did you know?
Vagelos and his wife Diana have donated hundreds of millions of dollars to Columbia University's medical school.
Net worth over time
Real-time ranking
Financial assets
NASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsImages © Forbes.com. All rights reserved.